🧵 Drug Combinations That Can Kill — Interactions You Must Never Miss
We prescribe these daily.
Get the combination wrong → bleeding, rhabdomyolysis, bone marrow suppression, cardiac arrest.
Here are the 10 combinations you must always check for 👇
@DrAkhilX @IhabFathiSulima @CelestinoGutirr @Janetbirdope @DurgaPrasannaM1 @SarahSchaferMD @NeuroSjogrens #MedTwitter #RheumTwitter
1) Allopurinol or Febuxostat + Azathioprine or 6-Mercaptopurine
❌ Severe bone marrow suppression (xanthine oxidase inhibition).
✅ Avoid the combination; if unavoidable, drastically reduce azathioprine dose and monitor blood counts closely — but switching is safer.
2) Methotrexate + Trimethoprim–Sulfamethoxazole (Co-trimoxazole)
❌ Pancytopenia, mucositis, acute kidney injury.
✅ Use alternatives such as nitrofurantoin or fosfomycin for urinary tract infections.
3) Colchicine + CYP3A4 or P-glycoprotein inhibitors (e.g., clarithromycin, verapamil, diltiazem, cyclosporine), especially in chronic kidney disease
❌ Toxicity and rhabdomyolysis, possible multi-organ failure.
✅ Prefer azithromycin; avoid combination or reduce colchicine dose significantly.
4) Simvastatin or Lovastatin + Strong CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole, protease inhibitors)
❌ Rhabdomyolysis.
✅ Switch to pravastatin or rosuvastatin, or change the interacting drug.
5) Warfarin + Trimethoprim–Sulfamethoxazole, Metronidazole, Azole antifungals, or Fluoroquinolones
❌ International Normalized Ratio (INR) spike → major bleeding.
✅ Reduce warfarin dose pre-emptively and monitor INR early, or choose a safer alternative.
6) Apixaban or Rivaroxaban + Strong CYP3A4 or P-glycoprotein inhibitors or inducers (e.g., ketoconazole, ritonavir, rifampicin, carbamazepine, phenytoin)
❌ Bleeding (with inhibitors) or clotting (with inducers).
✅ Avoid combination; change anticoagulant or interacting drug.
7) Angiotensin-converting enzyme inhibitor or Angiotensin receptor blocker + Spironolactone + Potassium supplements ± Trimethoprim–Sulfamethoxazole
❌ Dangerous hyperkalemia → arrhythmia (especially in chronic kidney disease or elderly).
✅ Avoid stacking; monitor potassium and creatinine closely; use non-trimethoprim antibiotics if possible.
8) Macrolide antibiotics or Fluoroquinolone antibiotics + Other QT-prolonging drugs (e.g., amiodarone, antipsychotics, methadone, tricyclic antidepressants)
❌ Torsades de pointes.
✅ Baseline ECG; avoid combination; consider doxycycline where appropriate.
9) Linezolid + Selective serotonin reuptake inhibitors (SSRIs), Serotonin–norepinephrine reuptake inhibitors (SNRIs), Monoamine oxidase inhibitors (MAOIs), or Triptans
❌ Serotonin syndrome.
✅ Hold serotonergic drugs if possible and monitor closely.
10) Nitrates (e.g., glyceryl trinitrate) + Phosphodiesterase-5 inhibitors (e.g., sildenafil, tadalafil)
❌ Profound hypotension.
✅ Never co-administer; observe washout periods of at least 24–48 hours depending on the drug.
📌 Takeaway
Most interactions are predictable if you know the mechanism.
Look out for:
– CYP3A4 and P-glycoprotein effects
– Bone marrow suppression
– Muscle toxicity
– QT prolongation
– Potassium overload
💬 Share this — it could prevent a catastrophe in your next prescription.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Gout is the most common inflammatory arthritis, yet nearly 80% of patients are suboptimally managed, leading to preventable flares, tophi, and joint damage.
Forget the old myths of “kings and diet.”
Here is the modern, evidence-based approach to gout management, aligned with ACR guidelines, for the busy clinician. 🧵
MYTH: Gout is purely a “lifestyle disease” fixed by diet.
FACT: Diet typically alters serum urate by ~1 mg/dL at most.
Gout is primarily a genetically determined disorder of renal urate under-excretion.
You cannot “diet away” established gout. Medication is usually required.
Tweet 3 - The Goal (Treat-to-Target)
The goal of therapy isn’t just stopping flares - it’s dissolving monosodium urate crystals.
That requires a Treat-to-Target strategy:
• Target serum urate < 6.0 mg/dL for all gout patients
• If tophi are present: < 5.0 mg/dL for faster crystal clearance
The Clinical Approach to a Positive Antinuclear Antibody (ANA):
A positive ANA is one of the most common consults in Internal Medicine, yet it is widely misunderstood.
Positive ANA ≠ Lupus.
It causes significant patient anxiety and unnecessary referrals.
Here is the evidence-based approach to interpreting a positive ANA for the busy clinician. 🧵
#MedEd #Rheumatology #MedTwitter @DrAkhilX @IhabFathiSulima #InternalMedicine #Lupus #MedicalEducation
First, understand the pre-test probability.
ANA is not a screening test for fatigue or nonspecific pain.
Why? Up to 20–30% of the healthy population has a positive ANA at 1:40 titer. Even at 1:160, ~5% of healthy individuals are positive.
#Diagnostics #ClinicalPearls #PrimaryCare
The Titer is the key to specificity.
• 1:40 to 1:80: Low positive. Low clinical significance in isolation.
• 1:160: Intermediate.
• ≥ 1:320: High positive. Higher specificity for autoimmune disease, but still requires clinical correlation.
Treat the patient, not the number.
Ozempic vs Mounjaro — the REAL 2025 comparison.
🧵Thread🔥👇
Everyone is talking about weight-loss drugs. But the REAL showdown is Ozempic vs Mounjaro — and the winner is clear.
Ozempic and Mounjaro should be prescribed ONLY after medical assessment — never self-started.
🧵 5 Lab Traps That Delay Lupus Diagnosis (with one example)
I’ve seen lupus hide behind “normal” labs more times than I can count.
Here are 5 lab traps that delay the diagnosis — with one real case that’ll stick with you. 🧵👇
@DrAkhilX @IhabFathiSulima @DrNikhilMD @Janetbirdope @DurgaPrasannaM1 #MedTwitter #RheumTwitter #Autoimmunity
1️⃣ “ANA is negative, so it’s not lupus.”
Wrong.
Early SLE can have low-titer or even transiently negative ANA.
🧠 If your gut says lupus, repeat it after a few weeks.
2️⃣ “CRP is high, so it must be infection.”
Not always.
Lupus flares often have normal CRP.
High CRP just means: check if there’s serositis, arthritis… or yes, infection.